Renal sympathetic nerve ablation: The new frontier in the treatment of hypertension

Current Hypertension Reports

Volumn 12, Issue 1, 2010, Pages 39-46

  Schlaich, Markus P ^a   Krum, Henry ^b   Sobotka, Paul A ^c,d  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

^d Ardian Inc   (United States)

Author keywords

Denervation; Hypertension; Renal; Sympathetic nervous system

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIURETIC AGENT; MOXONIDINE;

ARTERY DISSECTION; BLOOD PRESSURE REGULATION; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; EFFERENT NERVE; ESSENTIAL HYPERTENSION; EVIDENCE BASED PRACTICE; EXPERIMENTAL STUDY; HUMAN; KIDNEY DENERVATION; KIDNEY DISEASE; KIDNEY FAILURE; NEPHRECTOMY; NONHUMAN; PATIENT SAFETY; RENAL SYMPATHETIC NERVE ABLATION; REVIEW; SENSORY NERVE; SODIUM RETENTION; WATER RETENTION;

AFFERENT PATHWAYS; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CATHETER ABLATION; HUMANS; HYPERTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; NOREPINEPHRINE; PROGNOSIS; RETROSPECTIVE STUDIES; SYMPATHETIC NERVOUS SYSTEM;

EID: 77249109872     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0078-6     Document Type: Review

References (50)

1. V Perkovic R Huxley Y Wu, et al. 2007 The burden of blood pressure-related disease: a neglected priority for global health Hypertension 50 6 991 997 10.1161/HYPERTENSIONAHA.107.095497 1:CAS:528:DC%2BD2sXht1yku7nI 17954719 (Pubitemid 350172916)
2. PM Kearney M Whelton K Reynolds, et al. 2005 Global burden of hypertension: analysis of worldwide data Lancet 365 9455 217 223 15652604
3. GF DiBona 2004 The sympathetic nervous system and hypertension: recent developments Hypertension 43 2 147 150 10.1161/01.HYP.0000113047.47711.fa 1:CAS:528:DC%2BD2cXlvFegtA%3D%3D 14707153 (Pubitemid 38174164)
4. GF DiBona UC Kopp 1997 Neural control of renal function Physiol Rev 77 1 75 197 1:CAS:528:DyaK2sXhvVeqsrc%3D 9016301
5. BT Alexander AE Hendon G Ferril TM Dwyer 2005 Renal denervation abolishes hypertension in low-birth-weight offspring from pregnant rats with reduced uterine perfusion Hypertension 45 4 754 758 10.1161/01.HYP.0000153319.20340.2a 1:CAS:528:DC%2BD2MXisV2jtbg%3D 15699462 (Pubitemid 40418377)
6. S Kassab T Kato FC Wilkins, et al. 1995 Renal denervation attenuates the sodium retention and hypertension associated with obesity Hypertension 25 4 Pt 2 893 897 1:CAS:528:DyaK2MXlvVemt7Y%3D 7721450
7. RH Smithwick JE Thompson 1953 Splanchnicectomy for essential hypertension; results in 1, 266 cases J Am Med Assoc 152 16 1501 1504 1:STN:280:DyaG3s%2Fos1artg%3D%3D 13061307
8. DM Morrissey VS Brookes WT Cooke 1953 Sympathectomy in the treatment of hypertension, review of 122 cases Lancet 1 6757 403 408 10.1016/S0140-6736(53) 91589-X 1:STN:280:DyaG3s%2FkvVKquw%3D%3D 13024041
9. M Esler G Jennings B Biviano, et al. 1986 Mechanism of elevated plasma noradrenaline in the course of essential hypertension J Cardiovasc Pharmacol 8 Suppl 5 S39 S43 10.1097/00005344-198608005-00008 2427882
10. MP Schlaich E Lambert DM Kaye, et al. 2004 Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation Hypertension 43 2 169 175 10.1161/01.HYP.0000103160.35395.9E 1:CAS:528:DC%2BD2cXlvFegsg%3D%3D 14610101 (Pubitemid 38174169)
11. M Esler G Jennings G Lambert 1989 Noradrenaline release and the pathophysiology of primary human hypertension Am J Hypertens 2 3 Pt 2 140S 146S 1:STN:280:DyaL1M7ms1WhtA%3D%3D 2647104
12. GJ Hasking MD Esler GL Jennings, et al. 1986 Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity Circulation 73 4 615 621 1:STN:280:DyaL287jsVSltQ%3D%3D 3948363
13. A Aggarwal MD Esler MJ Morris, et al. 2003 Regional sympathetic effects of low-dose clonidine in heart failure Hypertension 41 3 553 557 10.1161/01.HYP.0000055779.93635.A2 1:CAS:528:DC%2BD3sXhsV2lu7s%3D 12623958 (Pubitemid 36314631)
14. M Petersson P Friberg G Eisenhofer, et al. 2005 Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure Eur Heart J 26 9 906 913 10.1093/eurheartj/ehi184 15764611 (Pubitemid 40676571)
15. L Barajas 1978 Innervation of the renal cortex Fed Proc 37 5 1192 1201 1:CAS:528:DyaE1cXhvVKlsro%3D 416969
16. E Bell-Reuss DL Trevino CW Gottschalk 1976 Effect of renal sympathetic nerve stimulation on proximal water and sodium reabsorption J Clin Invest 57 4 1104 1107 10.1172/JCI108355 1:STN:280:DyaE283jslynug%3D%3D 947953
17. H Kirchheim H Ehmke P Persson 1989 Sympathetic modulation of renal hemodynamics, renin release and sodium excretion Klin Wochenschr 67 17 858 864 10.1007/BF01717340 1:CAS:528:DyaK3cXptFynug%3D%3D 2681964
18. V Kon 1989 Neural control of renal circulation Miner Electrolyte Metab 15 1-2 33 43 1:STN:280:DyaL1M7is12qtw%3D%3D 2644521
19. AS Zanchetti 1977 Neural regulation of renin release: experimental evidence and clinical implications in arterial hypertension Circulation 56 5 691 698 1:CAS:528:DyaE1cXitVSgtA%3D%3D 912827
20. VM Campese 1997 Neurogenic factors and hypertension in chronic renal failure J Nephrol 10 4 184 187 1:STN:280:DyaK1c%2Fhsleltg%3D%3D 9377724
21. S Ye M Gamburd P Mozayeni, et al. 1998 A limited renal injury may cause a permanent form of neurogenic hypertension Am J Hypertens 11 6 Pt 1 723 728 10.1016/S0895-7061(98)00030-2 1:CAS:528:DyaK1cXktlers78%3D 9657632 (Pubitemid 28313692)
22. S Ye H Zhong V Yanamadala VM Campese 2002 Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity Am J Hypertens 15 8 717 724 10.1016/S0895-7061(02)02959-X 1:CAS:528:DC%2BD38Xms1aisLo%3D 12160195 (Pubitemid 34804278)
23. VM Campese 2000 Neurogenic factors and hypertension in renal disease Kidney Int 57 Suppl 75 S2 S6 10.1046/j.1523-1755.2000.07511.x
24. VM Campese E Kogosov 1995 Renal afferent denervation prevents hypertension in rats with chronic renal failure Hypertension 25 4 Pt 2 878 882 1:STN:280:DyaK2M3jvVSjsw%3D%3D 7721447
25. VM Campese E Kogosov M Koss 1995 Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat Am J Kidney Dis 26 5 861 865 10.1016/0272-6386(95)90456-5 1:STN:280:DyaK28%2FlsV2isA%3D%3D 7485145
26. GF DiBona 2002 Sympathetic nervous system and the kidney in hypertension Curr Opin Nephrol Hypertens 11 2 197 200 10.1097/00041552-200203000-00011 11856913 (Pubitemid 34194740)
27. GF DiBona 2003 Neural control of the kidney: past, present, and future Hypertension 41 3 Pt 2 621 624 10.1161/01.HYP.0000047205.52509.8A 1:CAS:528:DC%2BD3sXhsFWktbw%3D 12623969 (Pubitemid 36314564)
28. J Fajardo JM Lopez-Novoa 1986 Effect of chemical sympathectomy on renal hydroelectrolytic handling in dogs with chronic caval constriction Clin Physiol Biochem 4 4 252 256 1:CAS:528:DyaL28XlslSjtbw%3D 3530590
29. RA Norman Jr WR Murphy DJ Dzielak, et al. 1984 Role of the renal nerves in one-kidney, one clip hypertension in rats Hypertension 6 5 622 626 6389335
30. JA Joles HA Koomans 2004 Causes and consequences of increased sympathetic activity in renal disease Hypertension 43 4 699 706 10.1161/01.HYP.0000121881. 77212.b1 1:CAS:528:DC%2BD2cXit12msb0%3D 14981063 (Pubitemid 38405571)
31. LU Mailloux WE Haley 1998 Hypertension in the ESRD patient: pathophysiology, therapy, outcomes, and future directions Am J Kidney Dis 32 5 705 719 10.1016/S0272-6386(98)70146-5 1:STN:280:DyaK1M%2Fjs1ehtg%3D%3D 9820438
32. E Ritz I Rychlik F Locatelli S Halimi 1999 End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions Am J Kidney Dis 34 5 795 808 10.1016/S0272-6386(99)70035-1 1:STN:280:DC%2BD3c%2FjtVWqsg%3D%3D 10561134
33. MJ Klag PK Whelton BL Randall, et al. 1996 Blood pressure and end-stage renal disease in men N Engl J Med 334 1 13 18 10.1056/NEJM199601043340103 1:STN:280:DyaK287gsFakug%3D%3D 7494564 (Pubitemid 26012498)
34. SG Rostand JD Brunzell RO Cannon 3rd RG Victor 1991 Cardiovascular complications in renal failure J Am Soc Nephrol 2 6 1053 1062 1:STN:280:DyaK387jsFKqsg%3D%3D 1777585
35. CA Herzog JZ Ma AJ Collins 1998 Poor long-term survival after acute myocardial infarction among patients on long-term dialysis N Engl J Med 339 12 799 805 10.1056/NEJM199809173391203 1:STN:280:DyaK1cvgtVKntA%3D%3D 9738087 (Pubitemid 28447453)
36. J Coresh GL Wei G McQuillan, et al. 2001 Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 161 9 1207 1216 10.1001/archinte.161.9.1207 1:STN:280: DC%2BD3M3ptFSlsQ%3D%3D 11343443
37. M Tonelli C Bohm S Pandeya, et al. 2001 Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency Am J Kidney Dis 37 3 484 489 10.1016/S0272-6386(01)80004-4 1:CAS:528: DC%2BD3MXit1ektL8%3D 11228171
38. JM Lazarus C Hampers JP Merrill 1974 Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy Arch Intern Med 133 6 1059 1066 10.1001/archinte.133.6.1059 1:STN:280:DyaE2c7mvVWntg%3D%3D 4597951
39. G Ligtenberg PJ Blankestijn PL Oey, et al. 1999 Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure N Engl J Med 340 17 1321 1328 10.1056/NEJM199904293401704 1:CAS:528:DyaK1MXjtVWqtL4%3D 10219067 (Pubitemid 29196594)
40. G Grassi G Seravalle M Colombo, et al. 1998 Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans Circulation 97 20 2037 2042 1:STN:280:DyaK1c3nt1Sltw%3D%3D 9610534
41. K Narkiewicz CA Pesek M Kato, et al. 1998 Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea Hypertension 32 6 1039 1043 1:CAS:528:DyaK1MXitVWisA%3D%3D 9856970
42. HP Schobel T Fischer K Heuszer, et al. 1996 Preeclampsia-a state of sympathetic overactivity N Engl J Med 335 20 1480 1485 10.1056/ NEJM199611143352002 1:STN:280:DyaK2s%2Fjt1KksA%3D%3D 8890098 (Pubitemid 26376680)
43. C Zoccali F Mallamaci S Parlongo, et al. 2002 Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease Circulation 105 11 1354 1359 10.1161/hc1102.105261 1:CAS:528:DC%2BD38XjtFalsL8%3D 11901048 (Pubitemid 34260428)
44. O Vonend P Marsalek H Russ, et al. 2003 Moxonidine treatment of hypertensive patients with advanced renal failure J Hypertens 21 9 1709 1717 10.1097/00004872-200309000-00021 1:CAS:528:DC%2BD3sXmtl2ksLY%3D 12923404 (Pubitemid 37076355)
45. K Strojek W Grzeszczak J Gorska, et al. 2001 Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy? J Am Soc Nephrol 12 3 602 605 1:STN:280:DC%2BD3M3mvFSjtg%3D%3D 11181810
46. G Onesti KE Kim JA Greco, et al. 1975 Blood pressure regulation in end-stage renal disease and anephric man Circ Res 36 6 Suppl 1 145 152 1:STN:280:DyaE2M7ms12gsw%3D%3D 1093752
47. RT Getts SM Hazlett SB Sharma, et al. 2006 Regression of left ventricular hypertrophy after bilateral nephrectomy Nephrol Dial Transplant 21 4 1089 1091 10.1093/ndt/gfi321 16338944
48. MP Schlaich DM Kaye E Lambert, et al. 2003 Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy Circulation 108 5 560 565 10.1161/01.CIR.0000081775.72651.B6 12847071 (Pubitemid 36961170)
49. H Krum M Schlaich R Whitbourn, et al. 2009 Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 9671 1275 1281 10.1016/S0140-6736(09) 60566-3 19332353 This study presents the first data on the safety and efficacy of a novel catheter-based approach to functionally denervate the human kidney, demonstrating a favorable safety profile and substantial and sustained reductions in blood pressure
50. MP Schlaich PA Sobotka H Krum, et al. 2009 Renal sympathetic-nerve ablation for uncontrolled hypertension N Engl J Med 361 9 932 934 10.1056/NEJMc0904179 1:CAS:528:DC%2BD1MXhtVKhtbrL 19710497 This study reports on a patient treated with catheter-based renal nerve ablation, demonstrating a reduction in central sympathetic outflow indicative of a potential involvement of afferent nerve fibers in the sustained blood pressure reduction associated with the procedure